摘要
目的评价自体材料替代肺动脉在肺癌外科治疗中的价值。方法将104例肺血管受累的肺癌患者分为两组,自体材料替代肺动脉成形术组42例,常规肺动脉成形组62例。比较两组间术后并发症、肺功能状态以及生存率。结果两组在术后并发症、术后1年存活患者肺功能状态上无明显差异,而自体材料组术后1年生存率明显优于常规组,术后3年生存率两组无明显差异。结论自体材料替代肺动脉成形术临床疗效满意,值得推广应用。
Objective To evaluate the clinical value of pulmonary arterioplasty using autologous substitute for treatment of lung cancer. Methods A retrospective review was made on 104 patients with lung cancer whose pulmonary arteries were invaded by tumor or metastatic lymph nodes. They were assigned to one of two groups： group 1, patients who received pulmonary arterioplasty using autologous substitute（ n = 42）;group 2, patients who received routine pulmonary arterioplasty（ n = 62）. The postoperative complications, pulmonary function and survival rate of two groups were compared. Results There was no death following operation in all patients. In 2 groups, there was no significant difference in postoperative complications, pulmonary function and 3 - year survival rate, but there was significant difference in 1 - year survival rate. Conclusion Pulmonary arterioplasty using autologous substitute is easy to be manipulated and has perfect curative effects.
出处
《临床外科杂志》
2005年第9期566-568,共3页
Journal of Clinical Surgery
关键词
自体材料
肺动脉成形术
肺癌
autologous substitute
pulmonary arterioplasty
lung cancer
